awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38167350-9ACC86B8-1BEF-468E-919A-F3AF1B6567D6
Q38167350-9ACC86B8-1BEF-468E-919A-F3AF1B6567D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38167350-9ACC86B8-1BEF-468E-919A-F3AF1B6567D6
Current evaluation of alemtuzumab in multiple sclerosis.
P2860
Q38167350-9ACC86B8-1BEF-468E-919A-F3AF1B6567D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38167350-9ACC86B8-1BEF-468E-919A-F3AF1B6567D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39ed9abc685ae19931a679a9cf42c5920b80c566
P2860
Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis.